Rajeev Mohan (@rajeevcmohan) 's Twitter Profile
Rajeev Mohan

@rajeevcmohan

Heart Failure, LVAD, Tx Cardiologist @scrippshealth | @Georgetown Hoya and @DrexelMedicine Dragon. Scripps & @CedarsSinai Trained | Tweets = mine/not advice.

ID: 268561107

linkhttps://www.scripps.org/physicians/8711-dr-rajeev-mohan calendar_today19-03-2011 01:15:43

495 Tweet

2,2K Followers

1,1K Following

Dr. Purvi Parwani (@purviparwani) 's Twitter Profile Photo

Fantastic morning spent at the Scripps Health Clinical Advances in Heart Failure, Arrhythmias and Cardiogenic Shock Symposium! Thanks for inviting me to contribute to your program Rola Khedraki, MD, FACC Rajeev Mohan . Loved the panel organization bringing different CV subspecialties

Rola Khedraki, MD, FACC (@rolakhedrakimd) 's Twitter Profile Photo

Thank you to my course co-director Rajeev Mohan the planning committee Tom Heywood @dngibson2 Dr. John Rogers Dr Nick Olson, all the amazing faculty and attendees for helping us put on a fantastic conference! See you next year!#ScrippsHF_EP2024 Scripps Health

Rajeev Mohan (@rajeevcmohan) 's Twitter Profile Photo

Thank you to all the faculty for making #ScrippsHF_EP2024 such an incredible meeting. And thank you to my amazing partner Rola Khedraki, MD, FACC for all your hard work and particularly your amazing playlist!! Special thanks to Mr. Nichols for sharing his experience of having AL.

Thank you to all the faculty for making #ScrippsHF_EP2024 such an incredible meeting.  And thank you to my amazing partner <a href="/RolaKhedrakiMD/">Rola Khedraki, MD, FACC</a> for all your hard work and particularly your amazing playlist!! Special thanks to Mr. Nichols for sharing his experience of having AL.
Rola Khedraki, MD, FACC (@rolakhedrakimd) 's Twitter Profile Photo

Incredibly honored to have received the Attending of the Year Teaching Award. Thank you to the fellows who inspire my passion for teaching everyday with their curiosity and enthusiasm and to the physician educators who guided me here #DreamComeTrue 💫

Incredibly honored to have received the Attending of the Year Teaching Award. Thank you to the fellows who inspire my passion for teaching everyday with their curiosity and enthusiasm and to the physician educators who guided me here #DreamComeTrue 💫
Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

🚨🚨🚨 MAJOR news in the #amyloidosis world this morning with positive topline results of #HELIOS-B. #Vutrisiran met all primary & secondary endpoints. Let's break down what we know... #StanfordAmyloidCenter (1/13)

🚨🚨🚨 MAJOR news in the #amyloidosis world this morning with positive topline results of #HELIOS-B. #Vutrisiran met all primary &amp; secondary endpoints. Let's break down what we know...  #StanfordAmyloidCenter (1/13)
Vaishali Sanchorawala (@vsanchorawala) 's Twitter Profile Photo

I’m excited to share that my latest review article on AL amyloidosis is now published in the New England Journal of Medicine! BU Amyloidosis Center Boston U Chobanian & Avedisian School of Medicine Boston Medical Center Systemic Light Chain Amyloidosis | New England Journal of Medicine nejm.org/doi/pdf/10.105…

Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented <a href="/escardio/">European Society of Cardiology</a> &amp; simultaneously published in <a href="/NEJM/">NEJM</a>.  The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!
Rola Khedraki, MD, FACC (@rolakhedrakimd) 's Twitter Profile Photo

Thank you to our attendees and amazing speakers for an enriching day of #sarcoid #HCM #cardioonc and A LOT of #cardiacamyloid 🫀 Thank you to my incredible course co-directors Rajeev Mohan Marcus Anthony Urey MD for making this Scripps-UCSD collaboration possible! 🤩

Thank you to our attendees and amazing speakers for an enriching day of #sarcoid #HCM #cardioonc and A LOT of #cardiacamyloid 🫀

Thank you to my incredible course co-directors <a href="/RajeevCMohan/">Rajeev Mohan</a> <a href="/UreyTony/">Marcus Anthony Urey MD</a> for making this Scripps-UCSD collaboration possible! 🤩
Dr. Purvi Parwani (@purviparwani) 's Twitter Profile Photo

Fun Saturday discussing the role of #whyCMR at Scripps/UCSD cardiomyopathy and amyloid symposium. Insightful interaction and discussion with a fantastic group of #CVimagers and #HeartFailure clinicians for two days. Congratulations to the course director and faculty Rajeev Mohan

Fun Saturday discussing the role of #whyCMR at Scripps/UCSD cardiomyopathy and amyloid symposium. Insightful interaction and discussion with a fantastic group of #CVimagers and #HeartFailure clinicians for two days. Congratulations to the course director and faculty <a href="/RajeevCMohan/">Rajeev Mohan</a>
Mark Kittipibul MD (@vkittipibul) 's Twitter Profile Photo

Check out our review on atrial mechanics and interventions in Journal of Cardiac Failure HFxIC collab issue "Atrial interventions could ⬇️affect atrial function ➡️symptoms/HF" We discuss 1⃣ atrial mechanics 2⃣ atrial CM 3⃣ impact of atrial interventions 🧵1/6

Check out our review on atrial mechanics and interventions in <a href="/JCardFail/">Journal of Cardiac Failure</a> HFxIC collab issue

"Atrial interventions could ⬇️affect atrial function ➡️symptoms/HF"

We discuss
1⃣ atrial mechanics
2⃣ atrial CM
3⃣ impact of atrial interventions

🧵1/6
Marat Fudim, MD MHS (@fudimmarat) 's Twitter Profile Photo

Volume redistribution has been recognized as a driver of cardiopulmonary congestion and decompensation. Splanchnic nerves have been found to be the driver of this process! Who could benefit from Splanchnic Nerve Ablation in HFpEF? A🧵... JAMA Cardiology jamanetwork.com/journals/jamac…

Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

Another day, another #ATTR amyloidosis trial published in NEJM! Exciting late-breaker American Heart Association #AHA24, looking at 1+ year data with #CRISPR gene editing by Intellia Therapeutics. The bottom line is all good news – sustained #TTR reduction, positive clinical signals, promising

Another day, another #ATTR amyloidosis trial published in <a href="/NEJM/">NEJM</a>! Exciting late-breaker <a href="/American_Heart/">American Heart Association</a> #AHA24, looking at 1+ year data with #CRISPR gene editing by <a href="/intelliatx/">Intellia Therapeutics</a>. The bottom line is all good news – sustained #TTR reduction, positive clinical signals, promising
Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

Excited to see the second ever drug approval for #ATTR cardiomyopathy. Another triumph for science 🧪 and great news for patients. Congratulations to all who have been involved in this journey! #ATTRUBY BridgeBio Pharma Martha Grogan MD Kevin Alexander Kenneth Mahaffey Paul Cheng

Eric H Yang, MD (@datsunian) 's Twitter Profile Photo

A fantastic morning in La Jolla discussing all things #cardioonc with the awesome Scripps Cardiology Fellowship & a 🔥 journal club led by Stanford CVI HF bound Eson Ekpo, M.D.! 🙏 to Rola Khedraki, MD, FACC & Scripps Health for the generous hospitality to visit ur beautiful hospital & amazing fellows!

A fantastic morning in La Jolla discussing all things #cardioonc with the awesome <a href="/ScrippsCVFellow/">Scripps Cardiology Fellowship</a> &amp; a 🔥 journal club led by <a href="/StanfordCVI/">Stanford CVI</a> HF bound <a href="/CardiBeatMD/">Eson Ekpo, M.D.</a>!

🙏 to <a href="/RolaKhedrakiMD/">Rola Khedraki, MD, FACC</a> &amp; <a href="/ScrippsHealth/">Scripps Health</a> for the generous hospitality to visit ur beautiful hospital &amp; amazing fellows!
Ronald Witteles (@ron_witteles) 's Twitter Profile Photo

A monumental day for the #ATTR #amyloidosis field: #Vutrisiran is now FDA approved for ATTR-CM! The landmark #HELIOS-B trial hit 10/10 prespecified endpoints including improved all-cause mortality. Congratulations to everyone who contributed to the development/approval, and a

A monumental day for the #ATTR #amyloidosis field: #Vutrisiran is now FDA approved for ATTR-CM! The landmark #HELIOS-B trial hit 10/10 prespecified endpoints including improved all-cause mortality. Congratulations to everyone who contributed to the development/approval, and a